GMAB - Halozyme downgraded at Piper Sandler despite guidance raise
2024-06-07 09:16:13 ET
More on Halozyme Therapeutics
- Halozyme Therapeutics, Inc. (HALO) Q1 2024 Earnings Call Transcript
- Halozyme Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Halozyme's Strategic Partnerships Fueling Next-Gen Therapeutics
- Halozyme hits 52-week high as patent win prompts guidance raise
- Bristol-Myers says FDA has revised decision date on injected Opdivo